Amphastar Pharmaceuticals Q2 Earnings Call Highlights
Key Points Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better. Second-quarter revenue rose 5% to $183.9 million, while diluted EPS increased to $0.67 from $0.64
Trending
Key Points Interested in Alliance Entertainment Holding Corporation? Here are five stocks we like better. Fiscal 2026 growth accelerated: Revenue rose 8% to $1.15 billion, while gross profit
Key Points Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better. Second-quarter revenue rose 5% to $183.9 million, while diluted EPS increased to $0.67 from $0.64
Key Points Interested in Ardagh Metal Packaging S.A.? Here are five stocks we like better. Ardagh Metal Packaging raised full-year 2026 adjusted EBITDA guidance to $775 million-$790 million
Key Points Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better. Amphastar is shifting its strategy from complex generics toward proprietary drugs and
Key Points Interested in Pennon Group Plc? Here are five stocks we like better. Pennon returned to profitability in 2025/2026, with EBITDA up 55% and underlying operating profit more than
Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI
On its third-quarter 2026 earnings call, held on Oct. 22, 2026, Ardagh (NYSE:AMBP) raised its full-year earnings guidance. European beverage container demand remains steady as consumers shift away
"The best thing that happens to us is when a great company gets into temporary trouble... We want to buy them when they're on the operating table." Warren Buffett said in a 1999 interview with